The Journal of Drugs in Dermatology recognized dermatologist Andrew F. Alexis, M.D., M.P.H., for his more than 15 years of work to close gaps in the care of dermatology patients with skin of color by presenting him with the Innovations in Skin of Color Dermatology Award in September.
Dr. Alexis, who was honored at the Skin of Color Update meeting in New York City, has devoted his career to closing gaps in skin of color therapeutics, research and education in the specialty.
Dr. Alexis tells Dermatology Times that he was just out of a fellowship in dermatopharmacology at New York University (NYU) when he joined what was then the Skin of Color Center at St. Luke’s Roosevelt Hospital in New York City.
That was in 2004. By 2005, he was director of the center now named Mount Sinai West.
“Since that time, I have been focused on the Center’s mission of advancing patient care, education and research as it pertains to dermatologic conditions that are prevalent in patients with skin of color. And this was really borne out of a whole host of unmet needs in patients of color.
This is something that I experienced firsthand early in my career, which really was the spark that led me to focus on this area,” Dr. Alexis says.